RMD 0.63% $38.11 resmed inc

ResMed's profit down despite revenue rise, page-12

  1. 3,251 Posts.
    lightbulb Created with Sketch. 71
    From the free articles on MF
    Edward Vesely: ResMed Inc.
    (CHESS) (ASX: RMD)

    ResMed recently reported its financial results for the quarter ending 30 September 2016 showing revenue had increased by 13 percent. Margins were also up on the prior corresponding period, despite a fall in net income of 8.2%.

    Looking forward, the company’s recent Brightree acquisition puts ResMed in a good place with double-digit earnings growth expected from its new investment in the years ahead. ResMed’s shares have fallen almost 16% from recent highs in early August, which makes this a good time to start or add to your position.
 
watchlist Created with Sketch. Add RMD (ASX) to my watchlist
(20min delay)
Last
$38.11
Change
-0.240(0.63%)
Mkt cap ! $22.38B
Open High Low Value Volume
$38.50 $38.57 $37.66 $49.01M 1.287M

Buyers (Bids)

No. Vol. Price($)
1 6322 $38.11
 

Sellers (Offers)

Price($) Vol. No.
$38.12 8095 3
View Market Depth
Last trade - 16.10pm 27/11/2024 (20 minute delay) ?
RMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.